DXU

Dicloxacillin, open form

Created:	2014-08-25
Last modified:	2025-05-21

Find Related PDB Entry
1 entries where DXU is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	55
Chiral Atom Count	6
Bond Count	57
Aromatic Bond Count	6

2D diagram of DXU

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Dicloxacillin, open form
Synonyms	dicloxacillin - open form; (3R,4R,5R)-3-(2,6-dichlorophenyl)-N-{(1R)-1-[(2R,4S)-4-(dihydroxymethyl)-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-oxoethyl}-5-methyl-1,2-oxazolidine-4-carboxamide
Systematic Name (OpenEye OEToolkits)	(4R,5R)-3-[2,6-bis(chloranyl)phenyl]-N-[(1R)-1-[(2R,4S)-4-[bis(oxidanyl)methyl]-5,5-dimethyl-1,3-thiazolidin-2-yl]-2-oxidanylidene-ethyl]-5-methyl-1,2-oxazolidine-4-carboxamide
Formula	C₁₉ H₂₅ Cl₂ N₃ O₅ S
Molecular Weight	478.39
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(NC(C=O)C1SC(C(N1)C(O)O)(C)C)C3C(c2c(Cl)cccc2Cl)NOC3C
SMILES	CACTVS	3.385	C[CH]1ON[CH]([CH]1C(=O)N[CH](C=O)[CH]2N[CH](C(O)O)C(C)(C)S2)c3c(Cl)cccc3Cl
SMILES	OpenEye OEToolkits	1.7.6	CC1C(C(NO1)c2c(cccc2Cl)Cl)C(=O)NC(C=O)C3NC(C(S3)(C)C)C(O)O
Canonical SMILES	CACTVS	3.385	C[C@H]1ON[C@H]([C@H]1C(=O)N[C@H](C=O)[C@@H]2N[C@@H](C(O)O)C(C)(C)S2)c3c(Cl)cccc3Cl
Canonical SMILES	OpenEye OEToolkits	1.7.6	C[C@@H]1[C@@H](C(NO1)c2c(cccc2Cl)Cl)C(=O)N[C@H](C=O)[C@@H]3N[C@H](C(S3)(C)C)C(O)O
InChI	InChI	1.03	InChI=1S/C19H25Cl2N3O5S/c1-8-12(14(24-29-8)13-9(20)5-4-6-10(13)21)16(26)22-11(7-25)17-23-15(18(27)28)19(2,3)30-17/h4-8,11-12,14-15,17-18,23-24,27-28H,1-3H3,(H,22,26)/t8-,11-,12+,14-,15+,17-/m1/s1
InChIKey	InChI	1.03	AXRWQAUUTZEPPM-YSIYDJFASA-N

Related Resource References

Resource Name	Reference
PubChem	137349214

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.